EASL NAFLD Summit 2018

mark
By Mark D'Antonio

Gubra will be doing a talk about “Best animal models of NASH” and will bring novel poster data on our diet-induced and biopsy-confirmed ob/ob-NASH mouse model - now with advanced Fibrosis (F3) at baseline at the European Association for the Study of the Liver (EASL) in Geneva for the EASL Nonalcoholic Fatty Liver Disease (NAFLD) Summit from September 20th-22nd 2018. Good meeting. Not to be missed! http://www.easl.eu/nafld2018/